| Patent application number | Description | Published |
|---|
| 20080312169 | Cosmetic use of D-ribose - D-ribose is incorporated into a cosmetic composition and applied to the skin to reduce the length and area of wrinkles and to improve the complexion of the skin. | 12-18-2008 |
| 20090197818 | Use Of Ribose for Recovery From Anaesthesia - D-Ribose is administered before and after general anaesthesia to reduce the time to recover from the effects of general anaesthesia. Preferably, pyrogen-free D-Ribose is administered intravenously during general anaesthesia and the interval post-anaesthesia before oral administration can be resumed. D-Glucose may be co-administered to reduce the effect of hypoglycemia that may be seen with D-Ribose administration. | 08-06-2009 |
| 20090197819 | Compositions for improving and repairing skin - Compositions for improving the condition of the skin or for repairing damaged skin are disclosed. The compositions contain D-ribose as the active ingredient plus a penetrant to deliver D-ribose to the basal cells and dermis of the skin. Compositions further containing emollients and emulsifiers are disclosed. | 08-06-2009 |
| 20090232750 | Compositions for indoor tanning - Compositions for inducing a natural tan of the skin is disclosed. The compositions contain D-ribose as the active ingredient plus a penetrant to deliver D-ribose to the basal cells and dermis of the skin. Compositions further containing emollients and emulsifiers are preferred. | 09-17-2009 |
| 20090286750 | USE OF RIBOSE IN LESSENING THE CLINICAL SYMPTOMS OF ABERRANT FIRING OF NEURONS - A method for treating a mammal suffering from a condition caused by aberrant neuron firing is disclosed herein. The method includes administering (e.g., orally administering) to the mammal (e.g., a human patient) in need thereof a therapeutically effective amount of a composition including D-ribose. | 11-19-2009 |
| 20100055206 | Use of ribose in first response to acute myocardial infarction - D-ribose is administered to patients suffering an acute myocardial infarction during first response care, in order to prevent cardiac compromise. In those patients able to ingest fluids, two to five grams of D-ribose is administered orally. In a patients unable to ingest fluids, or in a patient with and intravenous line, pyrogen-free D-ribose is administered intravenously at a rate of 50-300 mg/kg/hour. | 03-04-2010 |
| 20100099630 | Method for improving ventilatory efficiency - This invention is a method of improving the function of the pulmonary arm of the cardiac-pulmonary axis by the administration of a pharmaceutical or nutritional supplement to a patient in which the function of the pulmonary arm is suboptimal, but not as a sequella of dysfunction of the cardiac arm. The exemplar patient is one suffering from chronic obstructive pulmonary disease. The preferred pentose is D-ribose, to be administered chronically. | 04-22-2010 |
| 20100189785 | Use of D-ribose for fatigued subjects - Low doses of D-ribose raise the level of fitness and lower the perception of fatigue in baby boomers aged 45-65 who perceive themselves as fatigued. The doses range from 0.100 grams to 3.0 grams, bid, for a total of 0.200 to 6.0 grams daily. Objective measures of cardiopulmonary parameters confirm the improvement of fitness and questionnaires confirm that quality of life and mental states are improved with D-ribose administration. | 07-29-2010 |
| 20110021446 | COMPOSITIONS AND METHODS FOR FEEDING POULTRY - Feed supplements for poultry raised using a rapid growth regimen are disclosed herein. The supplements include D-ribose in an amount effective to improve the resistance to cardiomyopathy in the poultry. Methods for feeding poultry are also disclosed herein. | 01-27-2011 |
